S&P 500   3,970.99 (+0.56%)
DOW   32,237.53 (+0.41%)
QQQ   310.89 (+0.37%)
AAPL   160.25 (+0.83%)
MSFT   280.57 (+1.05%)
META   206.01 (+0.85%)
GOOGL   105.44 (-0.15%)
AMZN   98.13 (-0.59%)
TSLA   190.41 (-0.94%)
NVDA   267.79 (-1.52%)
NIO   9.07 (-2.16%)
BABA   86.90 (+0.44%)
AMD   97.95 (-2.32%)
T   18.61 (+0.81%)
F   11.51 (+0.79%)
MU   61.16 (-0.29%)
CGC   1.90 (-0.52%)
GE   91.37 (-0.24%)
DIS   94.08 (-1.83%)
AMC   4.47 (+0.00%)
PFE   40.39 (+0.52%)
PYPL   73.88 (+1.82%)
NFLX   328.39 (+2.50%)
S&P 500   3,970.99 (+0.56%)
DOW   32,237.53 (+0.41%)
QQQ   310.89 (+0.37%)
AAPL   160.25 (+0.83%)
MSFT   280.57 (+1.05%)
META   206.01 (+0.85%)
GOOGL   105.44 (-0.15%)
AMZN   98.13 (-0.59%)
TSLA   190.41 (-0.94%)
NVDA   267.79 (-1.52%)
NIO   9.07 (-2.16%)
BABA   86.90 (+0.44%)
AMD   97.95 (-2.32%)
T   18.61 (+0.81%)
F   11.51 (+0.79%)
MU   61.16 (-0.29%)
CGC   1.90 (-0.52%)
GE   91.37 (-0.24%)
DIS   94.08 (-1.83%)
AMC   4.47 (+0.00%)
PFE   40.39 (+0.52%)
PYPL   73.88 (+1.82%)
NFLX   328.39 (+2.50%)
S&P 500   3,970.99 (+0.56%)
DOW   32,237.53 (+0.41%)
QQQ   310.89 (+0.37%)
AAPL   160.25 (+0.83%)
MSFT   280.57 (+1.05%)
META   206.01 (+0.85%)
GOOGL   105.44 (-0.15%)
AMZN   98.13 (-0.59%)
TSLA   190.41 (-0.94%)
NVDA   267.79 (-1.52%)
NIO   9.07 (-2.16%)
BABA   86.90 (+0.44%)
AMD   97.95 (-2.32%)
T   18.61 (+0.81%)
F   11.51 (+0.79%)
MU   61.16 (-0.29%)
CGC   1.90 (-0.52%)
GE   91.37 (-0.24%)
DIS   94.08 (-1.83%)
AMC   4.47 (+0.00%)
PFE   40.39 (+0.52%)
PYPL   73.88 (+1.82%)
NFLX   328.39 (+2.50%)
S&P 500   3,970.99 (+0.56%)
DOW   32,237.53 (+0.41%)
QQQ   310.89 (+0.37%)
AAPL   160.25 (+0.83%)
MSFT   280.57 (+1.05%)
META   206.01 (+0.85%)
GOOGL   105.44 (-0.15%)
AMZN   98.13 (-0.59%)
TSLA   190.41 (-0.94%)
NVDA   267.79 (-1.52%)
NIO   9.07 (-2.16%)
BABA   86.90 (+0.44%)
AMD   97.95 (-2.32%)
T   18.61 (+0.81%)
F   11.51 (+0.79%)
MU   61.16 (-0.29%)
CGC   1.90 (-0.52%)
GE   91.37 (-0.24%)
DIS   94.08 (-1.83%)
AMC   4.47 (+0.00%)
PFE   40.39 (+0.52%)
PYPL   73.88 (+1.82%)
NFLX   328.39 (+2.50%)
Top-Rated Stocks  
NASDAQ:NTLA

Intellia Therapeutics - NTLA Insider Trading & Ownership

$38.30
+1.12 (+3.01%)
(As of 03/24/2023 12:00 AM ET)
Add
Compare
Today's Range
$36.46
▼
$38.40
50-Day Range
$33.30
▼
$44.82
52-Week Range
$32.44
▼
$78.58
Volume
764,698 shs
Average Volume
1.19 million shs
Market Capitalization
$3.37 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$87.18

Intellia Therapeutics (NASDAQ:NTLA) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
3.90%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
3
Amount Of
Insider Selling
(Last 12 Months)
$431,933.68

NTLA Insider Buying and Selling by Quarter

Get NTLA Insider Trade Alerts

Want to know when executives and insiders are buying or selling Intellia Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Intellia Therapeutics Insider Trades History

Export to Excel
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/4/2023Glenn GoddardCFOSell2,427$37.21$90,308.6715,404  
1/4/2023John M LeonardCEOSell6,673$37.21$248,302.33766,825  
1/4/2023Laura Sepp-LorenzinoEVPSell2,508$37.21$93,322.6819,959  
(Data available from 1/1/2013 forward)












NTLA Insider Trading Activity - Frequently Asked Questions

Who is on Intellia Therapeutics's Insider Roster?

The list of insiders at Intellia Therapeutics includes Andrew Schiermeier, Caroline Dorsa, David Lebwohl, Glenn Goddard, Jean Francois Formela, John F Crowley, John M Leonard, Jose E Rivera, Laura Sepp-Lorenzino, and Perry A Karsen. Learn more on insiders at NTLA.

What percentage of Intellia Therapeutics stock is owned by insiders?

3.90% of Intellia Therapeutics stock is owned by insiders. Learn more on NTLA's insider holdings.

Which Intellia Therapeutics insiders have been selling company stock?

The following insiders have sold NTLA shares in the last 24 months: Caroline Dorsa ($616,425.00), David Lebwohl ($1,380,048.00), Glenn Goddard ($7,825,641.63), Jean Francois Formela ($102,364,127.43), John F Crowley ($1,604,275.00), John M Leonard ($14,760,225.30), Jose E Rivera ($4,160,519.30), and Laura Sepp-Lorenzino ($18,834,935.68).

How much insider selling is happening at Intellia Therapeutics?

Insiders have sold a total of 1,299,862 Intellia Therapeutics shares in the last 24 months for a total of $157,597,681.14 sold.

This page (NASDAQ:NTLA) was last updated on 3/24/2023 by MarketBeat.com Staff